Insmed (INSM) Operating Margin (QoQ) (2011 - 2026)
Powered by 
Analysis
Insmed (INSM) Operating Margin (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,975.00 |
| Mar 31, 2026 | 7,108.00 |
| Dec 31, 2025 | 13,594.00 |
| Sep 30, 2025 | 3,415.00 |
| Jun 30, 2025 | -2,395.00 |
| Mar 31, 2025 | -4,671.00 |
| Dec 31, 2024 | 784.00 |
| Sep 30, 2024 | 9,135.00 |
| Jun 30, 2024 | -12,707.00 |
| Mar 31, 2024 | 2,029.00 |
| Dec 31, 2023 | -2,626.00 |
| Sep 30, 2023 | 11,822.00 |
| Jun 30, 2023 | -7,779.00 |
| Mar 31, 2023 | 2,825.00 |
| Dec 31, 2022 | -6,690.00 |
| Sep 30, 2022 | -5,313.00 |
| Jun 30, 2022 | 3,374.00 |
| Mar 31, 2022 | 738.00 |
| Dec 31, 2021 | 4,507.00 |
| Sep 30, 2021 | -2,638.00 |